Epodyl in management of noninvasive vesical neoplasms.

Abstract	A prospective study to assess the effects of triethylene glycol diglyceridyl ether (Epodyl) in the management of superficial noninvasive vesical neoplasm (T1) is presented. Apart from a few local side effects, the response of the tumor to Epodyl was very good as assessed up to three years. Further long-term studies are being done.
Authors	J M SMith, V Lane, J D O'Flynn
Journal	Urology (Urology) Vol. 11 Issue 5 Pg. 474-7 (May 1978) ISSN: 0090-4295 [Print] United States
PMID	675901 (Publication Type: Journal Article)
Chemical References	Ethers Ethoglucid
Topics	Diathermy Ethers (therapeutic use) Ethoglucid (administration & dosage, adverse effects, therapeutic use) Female Follow-Up Studies Humans Male Neoplasm Recurrence, Local Urinary Bladder Neoplasms (drug therapy, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!